Literature DB >> 2936369

Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action.

M C Berenbaum, G W Hall, A D Hoyes.   

Abstract

Exposure of the cranium to white light in mice that had been given haematoporphyrin derivative (HpD) led to a rapid onset of vasogenic cerebral oedema, cerebral necrosis, coma and death. Selectivity of the initial damage for endothelium was suggested by (a) early breakdown (less than 1 h) of the blood-brain barrier (BBB) as shown by increased permeability to Evans blue (b) separation and increased vesiculation of endothelial cells at 2 h and (c) endothelial cell pyknosis at 3--4 h in small vessels next to apparently undamaged neurones and neuroglia. There was no damage to myelin sheaths, and astrocytes showed only end-feet oedema, a reaction to exudation of protein-rich fluid. Within a few hours of illumination, most cells in the illuminated area were necrotic. Cerebral photosensitivity persisted for at least 12 weeks after a single injection of HpD. Our results suggest that the primary site of damage in the brain is the endothelium of small vessels, and that HpD remains associated with this for a remarkably long time. These findings are relevant to the mechanisms by which photodynamic therapy damages other tissues, including neoplasms, and particularly to the possible application of this treatment to brain tumours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936369      PMCID: PMC2001468          DOI: 10.1038/bjc.1986.12

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues.

Authors:  R E Wharen; R E Anderson; E R Laws
Journal:  Neurosurgery       Date:  1983-04       Impact factor: 4.654

2.  Long term survival among patients with malignant brain tumors.

Authors:  A N Lieberman; S H Foo; J Ransohoff; A Wise; A George; W Gordon; R Walker
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

3.  Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study.

Authors:  E R Laws; D A Cortese; J H Kinsey; R T Eagan; R E Anderson
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

4.  Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model.

Authors:  J E Boggan; M S Edwards; M W Berns; R J Walter; C A Bolger
Journal:  Lasers Surg Med       Date:  1984       Impact factor: 4.025

5.  Regional studies of changes in brain fatty acids following experimental ischaemia and reperfusion in the gerbil.

Authors:  K K Bhakoo; H A Crockard; P T Lascelles
Journal:  J Neurochem       Date:  1984-10       Impact factor: 5.372

6.  Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light.

Authors:  S H Selman; M Kreimer-Birnbaum; J E Klaunig; P J Goldblatt; R W Keck; S L Britton
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

7.  Development of a protocol for photoradiation therapy of malignant brain tumors: part 1. Photosensitization of normal brain tissue with hematoporphyrin derivative.

Authors:  D E Rounds; S Jacques; C H Shelden; C A Shaller; R S Olson
Journal:  Neurosurgery       Date:  1982-10       Impact factor: 4.654

8.  Vascular occlusion and tumour cell death.

Authors:  J Denekamp; S A Hill; B Hobson
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

9.  Prostaglandin synthesis and oedema formation during reperfusion following experimental brain ischaemia in the gerbil.

Authors:  K K Bhakoo; H A Crockard; P C Lascelles; S F Avery
Journal:  Stroke       Date:  1984 Sep-Oct       Impact factor: 7.914

10.  In vivo biological activity of the components of haematoporphyrin derivative.

Authors:  M C Berenbaum; R Bonnett; P A Scourides
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

View more
  16 in total

1.  Uptake of a nido-carboranylporphyrin by human glioma xenografts in athymic nude mice and by syngeneic ovarian carcinomas in immunocompetent mice.

Authors:  S B Kahl; D D Joel; M M Nawrocky; P L Micca; K P Tran; G C Finkel; D N Slatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Neuronal injury after photoactivation of photofrin II.

Authors:  Y Yoshida; M O Dereski; J H Garcia; F W Hetzel; M Chopp
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

3.  In vivo magnetic resonance imaging of the effects of photodynamic therapy.

Authors:  N J Dodd; J V Moore; D G Poppitt; B Wood
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

4.  Quantitative histological changes in murine tail skin following photodynamic therapy.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

5.  Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study.

Authors:  K Benstead; J V Moore
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

6.  Photodynamic therapy effect in an intraocular retinoblastoma-like tumour assessed by an in vivo to in vitro colony forming assay.

Authors:  J Winther
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

7.  Modification by vasoactive drugs of tumour destruction by photodynamic therapy with haematoporphyrin derivative.

Authors:  P A Cowled; I J Forbes
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

8.  Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.

Authors:  E A Lindsay; M C Berenbaum; R Bonnett; D G Thomas
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

9.  meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.

Authors:  M C Berenbaum; S L Akande; R Bonnett; H Kaur; S Ioannou; R D White; U J Winfield
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

10.  Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.

Authors:  W E Grant; P M Speight; A J MacRobert; C Hopper; S G Bown
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.